This inventor holds 3 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: St. Jude Children's Research Hospital, The Procter Gamble Company. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016-2025
Title: Innovations and Contributions of Inventor Sourav Das
Introduction
Sourav Das is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate protein activity. With a total of 3 patents to his name, his work is recognized for its potential impact on treating various clinical conditions.
Latest Patents
Sourav Das's latest patents include innovative compounds such as substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs. These compounds are designed to act as modulators of cereblon protein activity. The patents detail methods of making these compounds, pharmaceutical compositions that include them, and their applications in treating disorders related to uncontrolled cellular proliferation, such as cancer. The disclosed compounds can selectively modulate the degradation of GSPT1 protein, showcasing their potential as GSPT1 degraders.
Career Highlights
Throughout his career, Sourav Das has worked with prominent organizations, including Procter & Gamble and St. Jude Children's Research Hospital. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.
Collaborations
Sourav has collaborated with several professionals in his field, including Fatemeh Keramatnia and Kevin McGowan. These collaborations have likely enhanced his research and innovation efforts.
Conclusion
Sourav Das is a distinguished inventor whose work in pharmaceutical innovations holds promise for advancing treatment options for various medical conditions. His contributions to the field are noteworthy and reflect his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile